Christopher Bethel Yesterday, the AP claimed that the DEA will likely be reclassifying cannabis from the program I (in a very group with heroin and lsd, i.e. a drug with no at this time approved clinical use and significant opportunity for abuse) to the timetable III drug (in the class with ketamine and anabolic steroids). This is vital - although